Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00594867 · ClinicalTrials.gov registry record · Phase 4
The Effects of Aspirin and Acetaminophen on the Stomach in Healthy Volunteers
A Phase 4 study, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- Phase 4
- Development phase
- 94
- Enrollment target
NCT00594867 is a Phase 4 study that has completed, run by University of Illinois at Chicago. The registered enrollment target is 94 participants.
The verdict
NCT00594867, a Phase 4 study, has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 94 participants
- Enrollment target
Study Summary
Aspirin is a medication commonly used to relieve minor pains. Aspirin has also been used to prevent heart attacks and strokes. Aspirin, however, can also cause damage to the stomach and/or intestinal lining leading to the development of erosions ("small sores") and/or ulcers ("large sores"). Erosions may cause bleeding ("bleeding ulcers") and/or perforations ("holes in the stomach"). Acetaminophen, often referred by the brand name, Tylenol, is also used to treat minor pains but is not commonly recognized to cause damage to the stomach lining. Many patients often take both of these medications together. While the effects on the stomach lining of each medication, when used alone, are known, the effects of both medications, when used together, are not. The purpose of this study is to show whether or not the collective effects of both aspirin and acetaminophen, when used together, increase the damage on the stomach lining when compared to either medication alone.
Interventions
- DRUG Acetaminophen - 4 grams per day + Placebo
- DRUG Aspirin - 325 mg per day + Placebo
- DRUG Acetaminophen 4 gram per day + Aspirin 325 mg per day
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2006-12 |
| Est. Completion | 2007-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00594867
The ClinicalTrials.gov registry entry for NCT00594867 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 94 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Acetaminophen - 4 grams per day + Placebo is the first listed.
NCT00594867 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00594867 about?
NCT00594867 is a clinical study titled "The Effects of Aspirin and Acetaminophen on the Stomach in Healthy Volunteers". Aspirin is a medication commonly used to relieve minor pains. Aspirin has also been used to prevent heart attacks and strokes. Aspirin, however, can also cause damage to the stomach and/or intestinal lining leading to the development of erosions ("small sores") and/or ulcers ("large sores"). Erosion...
What is the current status of trial NCT00594867?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 94 participants. The study started on 2006-12. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00594867?
The interventions under investigation include: Acetaminophen - 4 grams per day + Placebo (DRUG), Aspirin - 325 mg per day + Placebo (DRUG), Acetaminophen 4 gram per day + Aspirin 325 mg per day (DRUG).
Who is sponsoring clinical trial NCT00594867?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.